(+/-)-nonane-4-thiol | 1006684-25-8

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醇
• 英文名称: (+/-)-nonane-4-thiol
• 英文别名: Nonane-4-thiol
• CAS: 1006684-25-8
• 化学式: C₉H₂₀S
• 分子量: 160.324
• InChiKey: WZRWMBWPUCWZNN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  (+/-)-S-(1-propylhexyl) ethanethioate 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 以76%的产率得到(+/-)-nonane-4-thiol
  参考文献：
  名称：

  红灯笼椒（辣椒）的同时蒸馏萃取提取物中的新的挥发性挥发性含硫成分。

  摘要：

  通过同时蒸馏-萃取（SDE，Likens-Nickerson）制备红甜椒（Capsicum annuum）的提取物。除了已知的（3 E）-3-庚-2-酮（1）外，不饱和C9-酮1-壬烯-4-酮（2），（2 E）-2-壬烯-4-酮（3）和（2 E，5 E）-2,5-nonadien-4-one（4），2-甲氧基-3-异丁基吡嗪（5）和庚烷-2-硫醇（6），我们确定了19新硫醇（脂族饱和和不饱和硫醇14-16和22-27，巯基酮12和13，巯基醇17、18和30，二硫醇19和28，甲硫醇20和21 ，以及噻吩-硫醇31）和两个新的二噻吩10和29。它们在结构上均与不饱和C7-和C9-酮1-4相关。使用Affi-Gel 501（对氨基苯酚）富集了游离硫醇-乙酸汞接枝在琼脂糖凝胶上）。

  DOI：

  10.1021/jf072493y

文献信息

• Antibacterial compound
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030171330A1

  公开（公告）日：2003-09-11

  A compound of formula (I) 1 wherein R 1 and R 2 represent a hydrogen atom or an aryl, a heterocyclic, an alkyl or an alkenyl, which are optionally substituted, R 3 represents a hydrogen atom or a hydroxyl and X 1 and X 2 represent an oxygen atom, a sulfur atom or a nitrogen containing group, a pharmaceutically acceptable derivative thereof or a salt thereof. A pharmaceutical composition comprising the compound for the prevention or treatment of a bacterial infection. A method for the prevention or treatment of a bacterial infection in a warm-blooded animal comprising administering a pharmacologically effective amount of the compound.

  式（I）的化合物，其中R1和R2代表氢原子或芳基、杂环基、烷基或烯基，可以是可选择取代的；R3代表氢原子或羟基；X1和X2代表氧原子、硫原子或含氮基团，其药用上可接受的衍生物或盐。包括该化合物的药物组合物，用于预防或治疗细菌感染。一种方法，用于在温血动物中预防或治疗细菌感染，包括给予该化合物的药理有效量。
• Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
  申请人：Sankyo Company Limited

  公开号：EP0536936A1

  公开（公告）日：1993-04-14

  Compounds of formula (I): [in which: R¹, R² and R³ are the same or different and each represents a hydrogen atom, an optionally substituted alkanoyl group or an alkenylcarbonyl group, provided that at least one of R¹, R² and R³ represents an unsubstituted alkanoyl group having from 5 to 24 carbon atoms, said substituted alkanoyl group or said alkenylcarbonyl group; and one of R⁴ and R⁵ represents a hydrogen atom and the other represents a cyano group]; have valuable anti-tumour activity.

  式子（I）的化合物：[其中：R¹、R²和R³相同或不同，每个代表氢原子、可选取代的脂肪酰基团或烯基羰基团，前提是至少有一个R¹、R²和R³代表有5到24个碳原子的未取代脂肪酰基团，或者是所述取代的脂肪酰基团或所述烯基羰基团；R⁴和R⁵中的一个代表氢原子，另一个代表氰基]，具有有价值的抗肿瘤活性。
• Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0632036A2

  公开（公告）日：1995-01-04

  Compounds of formula (I): in which : R1 is alkyl or a group of formula (II), (III), (IV) or (V): and in which the groups R2, R3, R4 and R5 are hydrogen or various organic groups ; and pharmaceutically acceptable salts thereof are useful in the treatment and prophylaxis of hypercholesteremia and arteriosclerosis ; methods for the preparation of such compounds are also provided.

  式(I)化合物： 其中：R1 是烷基或式（II）、（III）、（IV）或（V）的基团： 其中基团 R2、R3、R4 和 R5 为氢或各种有机基团；其药学上可接受的盐类可用于治疗和预防高胆固醇血症和动脉硬化；还提供了制备此类化合物的方法。
• NOVEL A-500359 DERIVATIVES
  申请人：Sankyo Company, Limited

  公开号：EP1209166A1

  公开（公告）日：2002-05-29

  The present invention relates to a compound of formula (I) (wherein R1 and R2 represent an aryl group, a heterocyclic group, an alkyl group, an alkenyl group and the like which are optionally substituted, R3 represents a hydrogen atom or a hydroxyl group, and X1 and X2 represent an oxygen atom or a sulfur atom, or a nitrogen atom which may be substituted), a pharmaceutically acceptable derivative thereof or a salt thereof. The present invention also relates to a pharmaceutical composition comprising a compound described above as an active ingredient for the prevention or treatment of bacterial infections. The present invention includes the use of a compound described above in order to prepare a medicament effective in the prevention or treatment of bacterial infections. The present invention is concerned with a method for the prevention or treatment of bacterial infections in warm-blooded animals comprising administering a pharmacologically effective amount of a compound described above to them.

  本发明涉及一种式(I)化合物（其中 R1 和 R2 代表芳基、杂环基、烷基、烯基等任选被取代的基团，R3 代表氢原子或羟基，X1 和 X2 代表氧原子或硫原子或可被取代的氮原子）、其药学上可接受的衍生物或其盐。 本发明还涉及一种药物组合物，其中包含上述化合物作为活性成分，用于预防或治疗细菌感染。 本发明包括使用上述化合物制备有效预防或治疗细菌感染的药物。 本发明涉及一种预防或治疗温血动物细菌感染的方法，包括给温血动物服用药理有效量的上述化合物。
• WAFER WASHING METHOD, AND LIQUID CHEMICAL USED IN SAME
  申请人：Central Glass Company, Limited

  公开号：EP3340283A1

  公开（公告）日：2018-06-27

  [Object] To provide a water-repellent protective film-forming liquid chemical used in a process of cleaning a wafer by means of a cleaning machine whose liquid contact member contains a vinyl chloride resin. [Solution] A liquid chemical is used, which includes: an alkoxysilane represented by the following general formula [1]; at least one kind selected from the group consisting of a sulfonic acid represented by the following general formula [2], an anhydride of the sulfonic acid, a salt of the sulfonic acid and a sulfonic acid derivative represented by the following general formula [3]; and a diluent solvent containing at least one kind selected from the group consisting of a hydrocarbon, an ether and a thiol.         (R1)aSi(H)b(OR2)4-a-b     [1]         R3-S(=O)2OH     [2]         R3-S(=O)2O-Si(H)3-c(R4)c     [3]

  [目的]提供一种憎水保护膜形成液体化学品，用于通过液体接触部件含有氯乙烯树脂的清洗机清洗晶片的过程。 [解决方案] 使用一种液体化学品，其中包括：由以下通式[1]表示的烷氧基硅烷；至少一种从以下通式[2]表示的磺酸、磺酸的酸酐、磺酸的盐和以下通式[3]表示的磺酸衍生物组成的组中选出的物质；以及至少一种从碳氢化合物、醚和硫醇组成的组中选出的稀释溶剂。 (R1)aSi(H)b(OR2)4-a-b[1]。 R3-S(=O)2OH [2] R3-S(=O)2O-Si(H)3-c(R4)c [3]